Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UI030 in COVID-19 Patients
NCT05055414Phase 2Unknown
- Sponsor
- Korea United Pharm Inc.
- Start
- Nov 2021
- Primary completion
- Oct 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 2 trial of budesonide + arformoterol in coronavirus disease 2019 (COVID-19), sponsored by Korea United Pharm Inc.. Status: unknown.
02
Drugs
budesonide + arformoterol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05055414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05055414.